Qualitative risk assessment of follicle stimulating hormone injectable products.

Douglas T SteinkeOsman H ZarrougRaj MathurHelen KendrewJulian Jenkins

Published in: Expert opinion on drug delivery (2020)

The study identifies differences in the risks for both sharps injuries and dosing errors between FSH delivery options that practitioners should consider when making a treatment choice.

Keyphrases

risk assessment
human health
primary care
systematic review
patient safety
heavy metals
emergency department
dna methylation
hyaluronic acid
general practice
decision making
climate change
replacement therapy
quality improvement